You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Erlotinib Hydrochloride Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Erlotinib Hydrochloride by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
25mg
100mg
150mg

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Roche
Cipla
Mylan
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Pharmascience
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Pharmascience
Schwarz Pharma
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
DKSH
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Ortat
Zuellig Pharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Non-small Cell Lung Cancer
Pancreatic Cancer

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Erlotinib Hydrochloride Industry
Figure Erlotinib Hydrochloride Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Erlotinib Hydrochloride
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Erlotinib Hydrochloride
1.2.2 Downstream
Table Application Segment of Erlotinib Hydrochloride
Table Global Erlotinib Hydrochloride Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Erlotinib Hydrochloride Market by Type
3.1 By Type
3.1.1 25mg
Table Major Company List of 25mg
3.1.2 100mg
Table Major Company List of 100mg
3.1.3 150mg
Table Major Company List of 150mg
3.2 Market Size
Table Global Erlotinib Hydrochloride Market 2016-2020, by Type, in USD Million
Figure Global Erlotinib Hydrochloride Market Growth 2016-2020, by Type, in USD Million
Table Global Erlotinib Hydrochloride Market 2016-2020, by Type, in Volume
Figure Global Erlotinib Hydrochloride Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Erlotinib Hydrochloride Market Forecast 2021-2026, by Type, in USD Million
Table Global Erlotinib Hydrochloride Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Roche (Company Profile, Sales Data etc.)
4.1.1 Roche Profile
Table Roche Overview List
4.1.2 Roche Products & Services
4.1.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Cipla (Company Profile, Sales Data etc.)
4.2.1 Cipla Profile
Table Cipla Overview List
4.2.2 Cipla Products & Services
4.2.3 Cipla Business Operation Conditions
Table Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Mylan (Company Profile, Sales Data etc.)
4.3.1 Mylan Profile
Table Mylan Overview List
4.3.2 Mylan Products & Services
4.3.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Teva (Company Profile, Sales Data etc.)
4.4.1 Teva Profile
Table Teva Overview List
4.4.2 Teva Products & Services
4.4.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 OSI Pharmaceuticals (Company Profile, Sales Data etc.)
4.5.1 OSI Pharmaceuticals Profile
Table OSI Pharmaceuticals Overview List
4.5.2 OSI Pharmaceuticals Products & Services
4.5.3 OSI Pharmaceuticals Business Operation Conditions
Table Business Operation of OSI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Glenmark Pharmaceuticals (Company Profile, Sales Data etc.)
4.6.1 Glenmark Pharmaceuticals Profile
Table Glenmark Pharmaceuticals Overview List
4.6.2 Glenmark Pharmaceuticals Products & Services
4.6.3 Glenmark Pharmaceuticals Business Operation Conditions
Table Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Beacon Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Beacon Pharmaceuticals Profile
Table Beacon Pharmaceuticals Overview List
4.7.2 Beacon Pharmaceuticals Products & Services
4.7.3 Beacon Pharmaceuticals Business Operation Conditions
Table Business Operation of Beacon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Raichem Lifesciences (Company Profile, Sales Data etc.)
4.8.1 Raichem Lifesciences Profile
Table Raichem Lifesciences Overview List
4.8.2 Raichem Lifesciences Products & Services
4.8.3 Raichem Lifesciences Business Operation Conditions
Table Business Operation of Raichem Lifesciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 United Biotech (Company Profile, Sales Data etc.)
4.9.1 United Biotech Profile
Table United Biotech Overview List
4.9.2 United Biotech Products & Services
4.9.3 United Biotech Business Operation Conditions
Table Business Operation of United Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 CJ Corporation (Company Profile, Sales Data etc.)
4.10.1 CJ Corporation Profile
Table CJ Corporation Overview List
4.10.2 CJ Corporation Products & Services
4.10.3 CJ Corporation Business Operation Conditions
Table Business Operation of CJ Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Vivimed Labs (Company Profile, Sales Data etc.)
4.11.1 Vivimed Labs Profile
Table Vivimed Labs Overview List
4.11.2 Vivimed Labs Products & Services
4.11.3 Vivimed Labs Business Operation Conditions
Table Business Operation of Vivimed Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Boryung Pharmaceutical (Company Profile, Sales Data etc.)
4.12.1 Boryung Pharmaceutical Profile
Table Boryung Pharmaceutical Overview List
4.12.2 Boryung Pharmaceutical Products & Services
4.12.3 Boryung Pharmaceutical Business Operation Conditions
Table Business Operation of Boryung Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.13 Taj Pharmaceuticals (Company Profile, Sales Data etc.)
4.13.1 Taj Pharmaceuticals Profile
Table Taj Pharmaceuticals Overview List
4.13.2 Taj Pharmaceuticals Products & Services
4.13.3 Taj Pharmaceuticals Business Operation Conditions
Table Business Operation of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Pharmascience (Company Profile, Sales Data etc.)
4.14.1 Pharmascience Profile
Table Pharmascience Overview List
4.14.2 Pharmascience Products & Services
4.14.3 Pharmascience Business Operation Conditions
Table Business Operation of Pharmascience (Sales Revenue, Cost, Gross Margin)
4.15 Natco Pharma (Company Profile, Sales Data etc.)
4.15.1 Natco Pharma Profile
Table Natco Pharma Overview List
4.15.2 Natco Pharma Products & Services
4.15.3 Natco Pharma Business Operation Conditions
Table Business Operation of Natco Pharma (Sales Revenue, Cost, Gross Margin)
4.16 Intas Pharmaceuticals (Company Profile, Sales Data etc.)
4.16.1 Intas Pharmaceuticals Profile
Table Intas Pharmaceuticals Overview List
4.16.2 Intas Pharmaceuticals Products & Services
4.16.3 Intas Pharmaceuticals Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.17 RPG Life Sciences (Company Profile, Sales Data etc.)
4.17.1 RPG Life Sciences Profile
Table RPG Life Sciences Overview List
4.17.2 RPG Life Sciences Products & Services
4.17.3 RPG Life Sciences Business Operation Conditions
Table Business Operation of RPG Life Sciences (Sales Revenue, Cost, Gross Margin)
4.18 Pharmascience (Company Profile, Sales Data etc.)
4.18.1 Pharmascience Profile
Table Pharmascience Overview List
4.18.2 Pharmascience Products & Services
4.18.3 Pharmascience Business Operation Conditions
Table Business Operation of Pharmascience (Sales Revenue, Cost, Gross Margin)
4.19 Schwarz Pharma (Company Profile, Sales Data etc.)
4.19.1 Schwarz Pharma Profile
Table Schwarz Pharma Overview List
4.19.2 Schwarz Pharma Products & Services
4.19.3 Schwarz Pharma Business Operation Conditions
Table Business Operation of Schwarz Pharma (Sales Revenue, Cost, Gross Margin)
4.20 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
4.20.1 Dr. Reddy’s Laboratories Profile
Table Dr. Reddy’s Laboratories Overview List
4.20.2 Dr. Reddy’s Laboratories Products & Services
4.20.3 Dr. Reddy’s Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Cost, Gross Margin)
4.21 Glenmark Pharmaceuticals (Company Profile, Sales Data etc.)
4.21.1 Glenmark Pharmaceuticals Profile
Table Glenmark Pharmaceuticals Overview List
4.21.2 Glenmark Pharmaceuticals Products & Services
4.21.3 Glenmark Pharmaceuticals Business Operation Conditions
Table Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.22 Chugai Pharmaceutical (Company Profile, Sales Data etc.)
4.22.1 Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Overview List
4.22.2 Chugai Pharmaceutical Products & Services
4.22.3 Chugai Pharmaceutical Business Operation Conditions
Table Business Operation of Chugai Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.23 DKSH (Company Profile, Sales Data etc.)
4.23.1 DKSH Profile
Table DKSH Overview List
4.23.2 DKSH Products & Services
4.23.3 DKSH Business Operation Conditions
Table Business Operation of DKSH (Sales Revenue, Cost, Gross Margin)
4.24 Firma Chun Cheong (Company Profile, Sales Data etc.)
4.24.1 Firma Chun Cheong Profile
Table Firma Chun Cheong Overview List
4.24.2 Firma Chun Cheong Products & Services
4.24.3 Firma Chun Cheong Business Operation Conditions
Table Business Operation of Firma Chun Cheong (Sales Revenue, Cost, Gross Margin)
4.25 Kremers Urban Pharmaceuticals (Company Profile, Sales Data etc.)
4.25.1 Kremers Urban Pharmaceuticals Profile
Table Kremers Urban Pharmaceuticals Overview List
4.25.2 Kremers Urban Pharmaceuticals Products & Services
4.25.3 Kremers Urban Pharmaceuticals Business Operation Conditions
Table Business Operation of Kremers Urban Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.26 Ortat (Company Profile, Sales Data etc.)
4.26.1 Ortat Profile
Table Ortat Overview List
4.26.2 Ortat Products & Services
4.26.3 Ortat Business Operation Conditions
Table Business Operation of Ortat (Sales Revenue, Cost, Gross Margin)
4.27 Zuellig Pharma (Company Profile, Sales Data etc.)
4.27.1 Zuellig Pharma Profile
Table Zuellig Pharma Overview List
4.27.2 Zuellig Pharma Products & Services
4.27.3 Zuellig Pharma Business Operation Conditions
Table Business Operation of Zuellig Pharma (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Erlotinib Hydrochloride Sales Revenue 2016-2020, by Company, in USD Million
Table Global Erlotinib Hydrochloride Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Erlotinib Hydrochloride Sales Revenue Share in 2020, by Company, in USD Million
Table Global Erlotinib Hydrochloride Sales Volume 2016-2020, by Company, in Volume
Table Global Erlotinib Hydrochloride Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Erlotinib Hydrochloride Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Erlotinib Hydrochloride Market Concentration, in 2020
Figure Europe Erlotinib Hydrochloride Market Market Concentration, in 2020
Figure Asia-Pacific Erlotinib Hydrochloride MMarket Concentration, in 2020
Figure South America Erlotinib Hydrochloride Market Concentration, in 2020
Figure Middle East & Africa Erlotinib Hydrochloride Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Non-small Cell Lung Cancer
Figure Erlotinib Hydrochloride Demand in Non-small Cell Lung Cancer, 2016-2020, in USD Million
Figure Erlotinib Hydrochloride Demand in Non-small Cell Lung Cancer, 2016-2020, in Volume
6.1.2 Demand in Pancreatic Cancer
Figure Erlotinib Hydrochloride Demand in Pancreatic Cancer, 2016-2020, in USD Million
Figure Erlotinib Hydrochloride Demand in Pancreatic Cancer, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Erlotinib Hydrochloride Demand Forecast 2021-2026, by Application, in USD Million
Figure Erlotinib Hydrochloride Market Growth 2021-2026, by Application, in USD Million
Figure Erlotinib Hydrochloride Market Share in 2026, by Application, in USD Million
Table Erlotinib Hydrochloride Demand Forecast 2021-2026, by Application, in Volume
Table Erlotinib Hydrochloride Market Growth 2021-2026, by Application, in Volume
Table Erlotinib Hydrochloride Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Erlotinib Hydrochloride Production 2016-2020, by Region, in USD Million
Table Erlotinib Hydrochloride Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Erlotinib Hydrochloride Market 2016-2020, by Region, in USD Million
Table Global Erlotinib Hydrochloride Market Share 2016-2020, by Region, in USD Million
Table Global Erlotinib Hydrochloride Market 2016-2020, by Region, in Volume
Table Global Erlotinib Hydrochloride Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Erlotinib Hydrochloride Market Size and Growth 2016-2020, in USD Million
Figure North America Erlotinib Hydrochloride Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Erlotinib Hydrochloride Market Size 2016-2020, by Country, in USD Million
Table North America Erlotinib Hydrochloride Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Erlotinib Hydrochloride Market Size and Growth 2016-2020, in USD Million
Figure Europe Erlotinib Hydrochloride Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Erlotinib Hydrochloride Market Size 2016-2020, by Country, in USD Million
Table Europe Erlotinib Hydrochloride Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Erlotinib Hydrochloride Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Erlotinib Hydrochloride Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Erlotinib Hydrochloride Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Erlotinib Hydrochloride Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Erlotinib Hydrochloride Market Size and Growth 2016-2020, in USD Million
Figure South America Erlotinib Hydrochloride Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Erlotinib Hydrochloride Market Size 2016-2020, by Country, in USD Million
Table South America Erlotinib Hydrochloride Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Erlotinib Hydrochloride Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Erlotinib Hydrochloride Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Erlotinib Hydrochloride Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Erlotinib Hydrochloride Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Erlotinib Hydrochloride Market Forecast 2021-2026, by Region, in USD Million
Table Erlotinib Hydrochloride Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44235